HI HB1722

Prohibits health insurance policies (accident and health, hospital/medical service plans, and HMOs) from imposing cost-sharing requirements (deductibles, copayments, coinsurance) on breast cancer screenings, supplemental breast examinations, and diagnostic breast examinations.

Defines diagnostic breast examinations as medically necessary examinations used to evaluate abnormalities seen from screening or detected by other means, including diagnostic mammography, breast MRI, or breast ultrasound.

Defines supplemental breast examinations as screening exams performed in the absence of abnormalities but based on personal or family medical history or other risk factors, including breast MRI or ultrasound.

Exempts high deductible health plans (HDHPs) from zero cost-sharing requirements only to the extent necessary to preserve eligibility under Internal Revenue Code section 223, with an exception for preventative care items.

Effective January 1, 2025, applying to all health insurance plans issued or renewed on or after that date.